Procter & Gamble (NYSE:PG) PT Lowered to $163.00

Procter & Gamble (NYSE:PG) had its price objective reduced by Barclays from $174.00 to $163.00 in a report released on Thursday, Benzinga reports. They currently have an overweight rating on the stock.

Several other research firms have also weighed in on PG. JPMorgan Chase & Co. reduced their target price on Procter & Gamble from $181.00 to $179.00 and set an overweight rating on the stock in a report on Wednesday, July 31st. Argus lifted their target price on Procter & Gamble from $180.00 to $185.00 and gave the stock a buy rating in a report on Thursday, April 25th. TD Cowen started coverage on Procter & Gamble in a report on Tuesday, July 23rd. They set a buy rating and a $189.00 target price on the stock. Jefferies Financial Group lowered Procter & Gamble from a buy rating to a hold rating and reduced their target price for the stock from $182.00 to $175.00 in a report on Wednesday, July 24th. Finally, BNP Paribas started coverage on Procter & Gamble in a report on Monday, June 24th. They set an outperform rating and a $187.00 target price on the stock. Nine equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of Moderate Buy and an average price target of $173.95.

Procter & Gamble Stock Up 2.6 %

Shares of Procter & Gamble stock opened at $170.08 on Thursday. The company has a quick ratio of 0.48, a current ratio of 0.73 and a debt-to-equity ratio of 0.50. Procter & Gamble has a 12 month low of $141.45 and a 12 month high of $170.92. The business has a fifty day simple moving average of $166.28 and a 200 day simple moving average of $162.21. The stock has a market cap of $401.41 billion, a PE ratio of 27.79, a price-to-earnings-growth ratio of 3.60 and a beta of 0.41.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, topping analysts’ consensus estimates of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.33% and a net margin of 17.71%. The business had revenue of $20.53 billion during the quarter, compared to analysts’ expectations of $20.69 billion. During the same period in the previous year, the firm earned $1.37 earnings per share. The firm’s quarterly revenue was down .1% compared to the same quarter last year. Research analysts predict that Procter & Gamble will post 6.96 EPS for the current year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be given a dividend of $1.0065 per share. The ex-dividend date of this dividend is Friday, July 19th. This represents a $4.03 annualized dividend and a yield of 2.37%. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.85%.

Insider Activity at Procter & Gamble

In related news, CEO Gary A. Coombe sold 21,388 shares of the stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $164.98, for a total transaction of $3,528,592.24. Following the completion of the transaction, the chief executive officer now directly owns 36,854 shares of the company’s stock, valued at $6,080,172.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Procter & Gamble news, CEO Sundar G. Raman sold 31,924 shares of the company’s stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $166.95, for a total value of $5,329,711.80. Following the sale, the chief executive officer now owns 19,042 shares in the company, valued at $3,179,061.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Gary A. Coombe sold 21,388 shares of the company’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $164.98, for a total value of $3,528,592.24. Following the completion of the sale, the chief executive officer now owns 36,854 shares in the company, valued at approximately $6,080,172.92. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 62,461 shares of company stock valued at $10,392,774. Insiders own 0.17% of the company’s stock.

Hedge Funds Weigh In On Procter & Gamble

A number of large investors have recently made changes to their positions in the company. Alera Investment Advisors LLC increased its stake in shares of Procter & Gamble by 1.2% during the first quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock worth $812,000 after purchasing an additional 60 shares during the period. Hudson Value Partners LLC increased its stake in Procter & Gamble by 4.1% during the 2nd quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock worth $250,000 after acquiring an additional 60 shares during the period. Fiduciary Alliance LLC increased its stake in Procter & Gamble by 2.8% during the 2nd quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock worth $371,000 after acquiring an additional 61 shares during the period. Demars Financial Group LLC increased its stake in Procter & Gamble by 4.4% during the 4th quarter. Demars Financial Group LLC now owns 1,497 shares of the company’s stock worth $219,000 after acquiring an additional 63 shares during the period. Finally, LCM Capital Management Inc increased its stake in Procter & Gamble by 1.1% during the 1st quarter. LCM Capital Management Inc now owns 5,701 shares of the company’s stock worth $925,000 after acquiring an additional 63 shares during the period. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.